BACKGROUND AND PURPOSE: Stroke volume, an increasingly used end point in phase II trials, is considered stationary at least 30 days after the ictus. We investigated whether information conveyed by MR imaging measurements of the "final" infarct volume could be assessed as early as the subacute stage (days 3-6), rather than waiting for the chronic stage (days 30-45). MATERIALS AND METHODS: Ninety-five patients with middle cerebral artery stroke prospectively included in a multicenter study underwent MR imaging during the first 12 hours (MR imaging-1), between days 3 and 6 (MR imaging-2), and between days 30 and 45 (MR imaging-3). We first investigated the relationship between subacute (FLAIR-2) and chronic volumes (FLAIR-3), by using a linear regression model. We then tested the relationship between FLAIR volumes (either FLAIR-2 or FLAIR-3) and functional disability, measured by the mRS at the time of MR imaging-3, by using logistic regression. The performances of the models were assessed by using the AUC in ROC. RESULTS: A linear association between log FLAIR-2 and log FLAIR-3 volumes was observed. The proportion of FLAIR-3 variation, explained by FLAIR-2, was high (R(2) = 81%), without a covariate that improved this percentage. Both FLAIR-2 and FLAIR-3 were independent predictors of mRS (OR, 0.79 and 0.73; 95% CI, 0.64-0.97 and 0.56-0.96; P = .026 and .023). The performances of the models for the association between either FLAIR volume and mRS did not differ (AUC = 0.897 for FLAIR-2 and 0.888 for FLAIR-3). CONCLUSIONS: Stroke damage may be assessed by a subacute volume because subacute volume predicts the "true" final volume and provides the same clinical prognosis.
BACKGROUND AND PURPOSE:Stroke volume, an increasingly used end point in phase II trials, is considered stationary at least 30 days after the ictus. We investigated whether information conveyed by MR imaging measurements of the "final" infarct volume could be assessed as early as the subacute stage (days 3-6), rather than waiting for the chronic stage (days 30-45). MATERIALS AND METHODS: Ninety-five patients with middle cerebral artery stroke prospectively included in a multicenter study underwent MR imaging during the first 12 hours (MR imaging-1), between days 3 and 6 (MR imaging-2), and between days 30 and 45 (MR imaging-3). We first investigated the relationship between subacute (FLAIR-2) and chronic volumes (FLAIR-3), by using a linear regression model. We then tested the relationship between FLAIR volumes (either FLAIR-2 or FLAIR-3) and functional disability, measured by the mRS at the time of MR imaging-3, by using logistic regression. The performances of the models were assessed by using the AUC in ROC. RESULTS: A linear association between log FLAIR-2 and log FLAIR-3 volumes was observed. The proportion of FLAIR-3 variation, explained by FLAIR-2, was high (R(2) = 81%), without a covariate that improved this percentage. Both FLAIR-2 and FLAIR-3 were independent predictors of mRS (OR, 0.79 and 0.73; 95% CI, 0.64-0.97 and 0.56-0.96; P = .026 and .023). The performances of the models for the association between either FLAIR volume and mRS did not differ (AUC = 0.897 for FLAIR-2 and 0.888 for FLAIR-3). CONCLUSIONS:Stroke damage may be assessed by a subacute volume because subacute volume predicts the "true" final volume and provides the same clinical prognosis.
Authors: Gregory W Albers; Vincent N Thijs; Lawrence Wechsler; Stephanie Kemp; Gottfried Schlaug; Elaine Skalabrin; Roland Bammer; Wataru Kakuda; Maarten G Lansberg; Ashfaq Shuaib; William Coplin; Scott Hamilton; Michael Moseley; Michael P Marks Journal: Ann Neurol Date: 2006-11 Impact factor: 10.422
Authors: Max Wintermark; Gregory W Albers; Andrei V Alexandrov; Jeffry R Alger; Roland Bammer; Jean-Claude Baron; Stephen Davis; Bart M Demaerschalk; Colin P Derdeyn; Geoffrey A Donnan; James D Eastwood; Jochen B Fiebach; Marc Fisher; Karen L Furie; Gregory V Goldmakher; Werner Hacke; Chelsea S Kidwell; Stephan P Kloska; Martin Köhrmann; Walter Koroshetz; Ting-Yim Lee; Kennedy R Lees; Michael H Lev; David S Liebeskind; Leif Ostergaard; William J Powers; James Provenzale; Peter Schellinger; Robert Silbergleit; Alma Gregory Sorensen; Joanna Wardlaw; Ona Wu; Steven Warach Journal: Stroke Date: 2008-04-10 Impact factor: 7.914
Authors: Julio A Chalela; Dong-Wha Kang; Marie Luby; Mustapha Ezzeddine; Lawrence L Latour; Jason W Todd; Billy Dunn; Steven Warach Journal: Ann Neurol Date: 2004-01 Impact factor: 10.422
Authors: J Röther; P D Schellinger; A Gass; M Siebler; A Villringer; J B Fiebach; J Fiehler; O Jansen; T Kucinski; V Schoder; K Szabo; G J Junge-Hülsing; M Hennerici; H Zeumer; K Sartor; C Weiller; W Hacke Journal: Stroke Date: 2002-10 Impact factor: 7.914
Authors: Martin Ebinger; Soren Christensen; Deidre A De Silva; Mark W Parsons; Christopher R Levi; Kenneth S Butcher; Christopher F Bladin; P Alan Barber; Geoffrey A Donnan; Stephen M Davis Journal: Stroke Date: 2009-02-26 Impact factor: 7.914
Authors: King Chung Ho; Fabien Scalzo; Karthik V Sarma; William Speier; Suzie El-Saden; Corey Arnold Journal: J Med Imaging (Bellingham) Date: 2019-05-22
Authors: King Chung Ho; William Speier; Haoyue Zhang; Fabien Scalzo; Suzie El-Saden; Corey W Arnold Journal: IEEE Trans Med Imaging Date: 2019-02-25 Impact factor: 10.048
Authors: Patrik Michel; George Ntaios; Marc Reichhart; Christian Schindler; Julien Bogousslavsky; Philip Maeder; Reto Meuli; Max Wintermark Journal: Neuroradiology Date: 2011-08-02 Impact factor: 2.804
Authors: Steven J Warach; Marie Luby; Gregory W Albers; Roland Bammer; Andrew Bivard; Bruce C V Campbell; Colin Derdeyn; Jeremy J Heit; Pooja Khatri; Maarten G Lansberg; David S Liebeskind; Charles B L M Majoie; Michael P Marks; Bijoy K Menon; Keith W Muir; Mark W Parsons; Achala Vagal; Albert J Yoo; Andrei V Alexandrov; Jean-Claude Baron; David J Fiorella; Anthony J Furlan; Josep Puig; Peter D Schellinger; Max Wintermark Journal: Stroke Date: 2016-04-12 Impact factor: 7.914
Authors: Mark Krongold; Mohammed A Almekhlafi; Andrew M Demchuk; Shelagh B Coutts; Richard Frayne; Armin Eilaghi Journal: Neuroimage Clin Date: 2014-11-08 Impact factor: 4.881
Authors: Inger Havsteen; Christian Ovesen; Lasse Willer; Janus Damm Nybing; Karen Ægidius; Jacob Marstrand; Per Meden; Sverre Rosenbaum; Marie Norsker Folke; Hanne Christensen; Anders Christensen Journal: Front Neurol Date: 2017-12-18 Impact factor: 4.003